Description
+ Include: 35 videos + 35 file sub vtt + 30 pdfs, size: 6.29 GB
+ Target Audience: cardiologists, electrophysiologists, and cardiac surgeons
+ Sample video: contact me for sample video
+ Information:
1. Overview
The Scripps Health Advancing Cardiovascular Care Emerging Therapies and Strategies 2026 program provides a comprehensive review of the latest clinical breakthroughs in cardiovascular medicine. The course covers advanced management of heart failure, cardiogenic shock, structural interventions, complex cardiomyopathies, and electrophysiology, equipping practitioners with cutting-edge tools to optimize patient outcomes.
Course Date: May 8-9, 2026
This comprehensive continuing medical educational program is designed to equip physicians with the latest knowledge and tools for diagnosing and managing complex cardiovascular conditions. Through a focus on emerging therapies, innovative technologies, and evidence-based strategies, participants will gain practical insights to optimize patient outcomes in a variety of challenging clinical scenarios. Topics will include advancements in heart failure management, mechanical circulatory support, arrhythmia therapies, pulmonary hypertension, cardiogenic shock, and more. Upon completion of this course, participants will be better prepared to integrate cutting-edge therapies and technologies into their practice, improve diagnostic accuracy, and enhance patient-centered care for individuals with cardiovascular diseases.
2. Learning Objectives
- Analyze the latest evidence and clinical trial data to inform the management of heart failure, pulmonary hypertension, and cardiogenic shock.
- Identify appropriate patient populations for innovative treatments and integrate them into personalized, multidisciplinary care plans.
- Evaluate the role of emerging therapies and technologies, including renal artery denervation, Barostim, CCM, and M-TEER, in treating cardiovascular diseases.
- Develop systematic approaches to diagnosing complex cardiovascular conditions, including amyloidosis, hypertrophic cardiomyopathy (HCM), and cardiorenal syndrome.
- Optimize the use of advanced mechanical circulatory support devices like VA ECMO, Impella, and subcutaneous ICDs.
- Improve their understanding of the pathophysiology, clinical manifestations, and management strategies for conditions such as atrial fibrillation, ventricular tachycardia, and shock.
3. Target Audience
Best for cardiologists, electrophysiologists, and cardiac surgeons who want advanced updates on heart failure, structural interventions, and pacing.
4. Topics
-
01 When to Refer to Advanced Heart Failure VIDEO PDF NOT RELEASE
-
02 What’s New in HFpEF Trials
-
03 Finerenone Who, When, and How
-
04 Beyond GDMT Barostim and CCM
-
05 Exercise Testing in Heart Failure
-
06 Cardiorenal Syndrome
-
07 Panel DiscussionQ&A
-
08 Role of Renal Artery Denervation
-
09 Acute PE Shock
-
10 TAVR in Cardiogenic Shock
-
11 TTVR vs T-TEER
-
12 Role of M-TEER in Cardiogenic Shock
-
13 Panel DiscussionQ&A
-
14 Stages of Shock
-
15 Elements of an ECPR Program
-
16 Troubleshooting MCS at 1 a.m. VIDEO PDF NOT RELEASE
-
17 Life Hacks for Managing VA ECMO Well
-
18 Life Hacks for Managing Impella Well VIDEO PDF NOT RELEASE
-
19 The Cardiogenic Shock Survivor
-
20 Panel DiscussionQ&A
-
21 Amyloid Diagnosis and Treatment
-
22 Therapies in ATTR-CM
-
23 Therapies in AL-CM
-
24 HCM Mimickers and Treatment
-
25 Advanced Imaging in Cardiomyopathies
-
26 The Amyloid Patient
-
27 Panel DiscussionQ&A
-
28 The Different Flavors of Pulmonary Hypertension
-
29 The Patient Has Pulmonary Hypertension, Now What
-
30 Pulmonary Hypertension in Congenital Heart Disease
-
31 CTEPH When to Refer for Surgery
-
32 Panel DiscussionQ&A
-
33 Atrial Fibrillation Ablation What’s New
-
34 Ventricular Tachycardia Ischemic vs. Nonischemic
-
35 Leadless Pacemakers
-
36 Subcutaneous ICDs
-
37 Left Bundle Pacing Are We Ready
-
38 Panel DiscussionQ&A
Reviews
There are no reviews yet.